Serial Number | 98219801 |
Word Mark | CELEST |
Filing Date | Wednesday, October 11, 2023 |
Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
Status Date | Wednesday, October 30, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Drug delivery agents in the form of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds directed to lipid nanoparticles for the purpose of delivering pharmaceutical preparations to specific target tissue sites; drug delivery agents in the form of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds and agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations; drug delivery agents consisting of pharmaceutical preparations and therapeutic agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations for RNA, gene therapy and mRNA regulation; drug delivery agents consisting of pharmaceutical and biological preparations for medical use that facilitate the release and delivery of a wide variety of pharmaceutical preparations for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; drug delivery agents consisting of pharmaceutical preparations that facilitate the release and delivery of a wide variety of pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation; pharmaceutical preparations, namely, vaccines |
Goods and Services | Chemical and biological agents for scientific and research use, namely, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acids and modified nucleic acids, namey, short RNAs and messenger RNAs; nucleic acid sequences for scientific purposes, research purposes, and laboratory purposes other than medical and veterinary purposes |
Goods and Services | Research and development in the field of technology and engineering, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, drug delivery agents and RNAs for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, RNAs, namely, developing molecular and cellular biology reagents, techniques, drug delivery agents and assays for use in pharmaceutical and biomedical industry |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Monday, October 16, 2023 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, October 16, 2023 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, October 16, 2023 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | ReNAgade Therapeutics Management, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Watertown, MA 02472 |
Event Date | Event Description |
Saturday, October 14, 2023 | NEW APPLICATION ENTERED |
Monday, October 16, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, April 26, 2024 | ASSIGNED TO EXAMINER |
Friday, May 17, 2024 | NON-FINAL ACTION E-MAILED |
Monday, July 15, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Monday, July 15, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Friday, October 4, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, May 17, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, May 17, 2024 | NON-FINAL ACTION WRITTEN |
Friday, October 4, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Friday, October 4, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Friday, October 4, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Wednesday, October 30, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, October 30, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, October 30, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, October 4, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |